PLI Schemes Attract ₹1.76 Lakh crore Investments, Create 1.2 Million Jobs | Current Affairs | Vision IAS
MENU
Home

Periodically curated articles and updates on national and international developments relevant for UPSC Civil Services Examination.

Quick Links

High-quality MCQs and Mains Answer Writing to sharpen skills and reinforce learning every day.

Watch explainer and thematic concept-building videos under initiatives like Deep Dive, Master Classes, etc., on important UPSC topics.

ESC

Daily News Summary

Get concise and efficient summaries of key articles from prominent newspapers. Our daily news digest ensures quick reading and easy understanding, helping you stay informed about important events and developments without spending hours going through full articles. Perfect for focused and timely updates.

News Summary

Sun Mon Tue Wed Thu Fri Sat

PLI Schemes Attract ₹1.76 Lakh crore Investments, Create 1.2 Million Jobs

26 Jun 2025
2 min

Overview of India's PLI Schemes

India's 14 Production Linked Incentive (PLI) schemes have attracted investments worth ₹1.76 lakh crore, generated production exceeding ₹16.5 lakh crore, and created over 1.2 million jobs as of March, according to a government statement following a review meeting led by Commerce and Industry Minister. The minister emphasized the need for a roadmap for the scheme over the next five years regarding investment and disbursement.

Key Statistics and Outcomes

  • Cumulative incentive amount disbursed: ₹21,534 crore for 12 sectors.
  • Major Sectors Involved:
    • Large-Scale Electronics Manufacturing (LSEM)
    • IT Hardware
    • Bulk Drugs
    • Medical Devices
    • Pharmaceuticals
    • Telecom & Networking Products
    • Food Processing
    • White Goods
    • Automobiles & Auto Components
    • Specialty Steel
    • Textiles
    • Drones & Drone Components

Sector-Specific Achievements

  • Pharmaceuticals:
    • Total sales: ₹2.66 lakh crore.
    • Exports: ₹1.70 lakh crore in the first three years.
    • Export sales for FY25: ₹67,000 crore (27% of total pharma exports).
  • Research & Development:
    • 40% of total investment (₹37,306 crore) amounts to ₹15,102 crore.
    • Domestic value addition: 83.7% as of March.
  • Bulk Drugs:
    • Net exporter at ₹2,280 crore in FY25 from a net importer at ₹1,930 crore in FY22.
  • Food Products:
    • Investments: ₹9,032 crore.
    • Sales: ₹3.8 lakh crore.
    • Jobs created: 340,000.
    • Increased local raw material procurement, benefiting rural areas and farmers.

Other Notable Developments

  • MSMEs:
    • 70 MSMEs directly enrolled and 40 others as contract manufacturers.
  • Marine Products:
    • Sales increased at 22% compounded annually during the PLI period.
  • Millet Scheme:
    • Sales of Millet Based Products increased 25 times in FY25 over FY21.

Explore Related Content

Discover more articles, videos, and terms related to this topic

RELATED VIDEOS

1
News Today (Jul 11, 2024)

News Today (Jul 11, 2024)

YouTube HD
Title is required. Maximum 500 characters.

Search Notes

Filter Notes

Loading your notes...
Searching your notes...
Loading more notes...
You've reached the end of your notes

No notes yet

Create your first note to get started.

No notes found

Try adjusting your search criteria or clear the search.

Saving...
Saved

Please select a subject.

Referenced Articles

linked

No references added yet

Subscribe for Premium Features